Erik H. Jensen

Glostrup, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis.

Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis.

Journal: Multiple sclerosis and related disorders
Published: February 24, 2024

Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis.

Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis.

Journal: Journal of neuroimmunology
Published: March 19, 2022

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.

Journal: BMC medicine
Published: May 14, 2020

Host-specific competitiveness to form nodules in Rhizobium leguminosarum symbiovar viciae.

Host-specific competitiveness to form nodules in Rhizobium leguminosarum symbiovar viciae.

Journal: The New phytologist
Published: November 22, 2019

Diagnostic Value of Oligoclonal Bands in Children: A Nationwide Population-Based Cohort Study.

Diagnostic Value of Oligoclonal Bands in Children: A Nationwide Population-Based Cohort Study.

Journal: Pediatric neurology
Published: January 08, 2019

Clinical utility of anti-MOG antibody testing in a Danish cohort.

Clinical utility of anti-MOG antibody testing in a Danish cohort.

Journal: Multiple sclerosis and related disorders
Published: September 05, 2018

Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.

Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 17, 2018

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.

Journal: Journal of neuroimmunology
Published: July 09, 2018

Oral Immunosuppressive Treatment of Myasthenia Gravis in Denmark: A Nationwide Drug Utilization Study, 1996-2013.

Oral Immunosuppressive Treatment of Myasthenia Gravis in Denmark: A Nationwide Drug Utilization Study, 1996-2013.

Journal: Basic & clinical pharmacology & toxicology
Published: February 05, 2018

Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.

Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.

Journal: Multiple sclerosis and related disorders
Published: January 05, 2018

Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.

Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.

Journal: JCI insight
Published: December 19, 2017

Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study.

Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study.

Journal: Journal of the neurological sciences
Published: November 22, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026